CDT Equity Q1 FY26 net loss narrows 14.52% to $4.06 million
CDT•Expenses, other loss items, and cash use
R&D expense fell 15% to $778,000, while general and administrative costs rose 7% to $2.88 million.
Other expense narrowed to $407,000 from $1.14 million, while loss on equity method investment was $68,000 after a Sarborg stake.
Cash used in operations improved to $1.89 million from $3.93 million, while management flagged substantial doubt about going-concern status.
Q1 net loss narrows, but operating loss widens
CDT Equity posted a net loss of $4.06 million for Q1 2026, narrowing from $4.75 million a year earlier.
Operating loss widened to $3.66 million, as operating costs edged up to $3.66 million from $3.62 million.
